Isifo seGilbert

IGilbert syndrome yisifo esivamile esidluliselwa emindenini. Ithinta indlela i-bilirubin icutshungulwa ngayo yisibindi, futhi ingadala ukuthi isikhumba sithathe umbala ophuzi (i-jaundice) kwesinye isikhathi.

IGilbert syndrome ithinta umuntu oyedwa kwabayishumi kwamanye amaqembu amhlophe. Lesi simo senzeka ngenxa yofuzo olungajwayelekile, oludluliselwa kusuka kubazali luye ezinganeni zabo.

Izimpawu zingafaka:

• Ukukhathala
• Ukuphuzi kwesikhumba nabamhlophe bamehlo (i-jaundice emnene)

Kubantu abane-Gilbert syndrome, i-jaundice ivame ukuvela ngezikhathi zokuzikhandla, ukucindezeleka, kanye nokutheleleka, noma uma bengadli.

Ukuhlolwa kwegazi kwe-bilirubin kukhombisa ushintsho olwenzeka nge-Gilbert syndrome. Izinga eliphelele le-bilirubin liphakanyisiwe kancane, iningi liyi-bilirubin enganqunyelwe. Imvamisa izinga eliphelele lingaphansi kuka-2 mg / dL, futhi ilejuli ebunjiwe ye-bilirubin ijwayelekile.

IGilbert syndrome ixhunyaniswe nenkinga yezofuzo, kepha ukuhlolwa kofuzo akudingeki.

Akukho ukwelashwa okudingekayo ku-Gilbert syndrome.

I-jaundice ingafika futhi ihambe impilo yonke. Kungenzeka ukuthi ivele ngesikhathi sokugula okufana nemikhuhlane. Akubangeli izinkinga zempilo. Noma kunjalo, ingadida imiphumela yokuhlolwa kwe-jaundice.

Azikho izinkinga ezaziwayo.

Shayela umhlinzeki wakho wezokunakekelwa kwezempilo uma une-jaundice noma ubuhlungu esiswini obungapheli.

Akukho ukuvimbela okuqinisekisiwe.

Icterus intermittens juvenilis; I-hyperbilirubinemia engapheli; I-jaundice ejwayelekile engeyona i-hemolytic-non-obstruction; Ukungasebenzi kwesibindi ngokomthethosisekelo; I-bilignubinemia engaxhunywanga; Isifo sikaGilbert

• Uhlelo lokugaya ukudla

IBerk PD, iKorenblat KM. Sondela esigulini nge-jaundice noma imiphumela yokuhlolwa kwesibindi engavamile. Ku: IGoldman L, iSchafer AI, ama-eds. Imithi yeGoldman-Cecil. Umhla ka-25. IPhiladelphia, PA: Elsevier Saunders; 2016: isahluko 147.

ILidofsky SD. I-jaundice. Ku: Feldman M, Friedman LS, Brandt LJ, ama-eds. ISleisenger neFordtran's Gastrointestinal and Liver Disease: IPathophysiology / Diagnosis / Management. Umhlaka 10. IPhiladelphia, PA: Elsevier Saunders; 2016: isahluko 21.

Theise ND. Isibindi nenyongo. Ku: Kumar V, Abbas AK, Fausto N, Aster JC, abahleli. AmaRobbins kanye neCotran Pathologic Basis of Disease. Umhlaka 9. IPhiladelphia, PA: Elsevier Saunders; 2015: isahluko 18.